• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Novartis & Alcon's takeover
 

Novartis & Alcon's takeover

on

  • 1,205 views

Analysis of Novartis & Alcon's takeover in 2009

Analysis of Novartis & Alcon's takeover in 2009

Statistics

Views

Total Views
1,205
Views on SlideShare
1,201
Embed Views
4

Actions

Likes
0
Downloads
23
Comments
0

1 Embed 4

http://www.linkedin.com 4

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Novartis & Alcon's takeover Novartis & Alcon's takeover Presentation Transcript

    • Novartis & Alcon
      The takeover
      Jérémie LORRAIN & Kelly BLASCO
    • Introduction
      What is a Takeover?
      Friendly
      Hostile
    • Overview
      Presentation of the companies
      Reasons of the takeover
      Stock Market
      How does Novartis finance it?
    • Novartis
      Swiss pharmaceutical company
      Created in 1996
      2009 turnover: $ 44,3 billion
      Employees: 100 000
    • Alcon
      American pharmaceutical firm
      Founded in 1945 by R.Alexander & W.Coner
      2008 turnover: $ 6 293 billion
      Employees: 15 000
    • Reasons of the takeover
      28 billion dollars
      Strengthen innovation power & diversify its range of medication
      Together they cover more than 70% of the global vision care sector
      Benefice for the shareholders, employees and patients
    • Stock Market - Alcon
      19th February stock price : $ 159.08
      15th March stock price: $162.48
    • Stock Market - Novartis
      • 5thfebruary: Novartis’ shares were worth 57,75 dollars
      • Today: 58,35 dollars
    • How does Novartis finance it?
      $14 billion to be financed
      Strong cash flow
      Mix of bonds and loans
      Selling shares
    • Conclusion
      Future success ?